Subtotal colectomy versus left hemicolectomy for the elective treatment of splenic flexure colonic neoplasia - 19/07/18
, Francesc Vallribera a , Albert García b , Laura Mora b , Sebastiano Biondo c , Jaime Lopez-Borao c , Ramon Farrés d , Júlia Gil d , Eloy Espin a Abstract |
Background |
Optimal elective surgical treatment for splenic flexure neoplasm (SFN) is unclear. Subtotal colectomy (STC) and left hemicolectomy (LHC) are the two more common strategies used.
Methods |
Observational multicentric study comparing postoperative morbidity, mortality and long-term survival on patients with SFN electively operated by STC versus LHC between 2003 and 2014.
Results |
After revision of the databases, 144 patients were included (STC group, n = 68; LHC group, n = 76). No differences were found on epidemiological and surgical data. A higher global morbidity (58%vs37%, p = 0.014), surgical morbidity (50%vs33%, p = 0.037), postoperative ileus (37%vs20%, p = 0.023) and harvested lymph nodes (26vs18, p = 0.0001) were found on the STC group. No significant differences in complications according to severity, reoperation rate, hospital stay, mortality, recurrence or long-term survival were found between groups.
Conclusions |
A higher surgical morbidity was found on the STC group, mainly due to mild postoperative ileus. No differences on long-term oncological results were found.
El texto completo de este artículo está disponible en PDF.Keywords : Splenic flexure, Carcinoma, Colon cancer, Surgery, Subtotal colectomy, Left hemicolectomy
Esquema
Vol 216 - N° 2
P. 251-254 - août 2018 Regresar al número
Artículo precedente
- Colorectal cancer screening in rural and poor-resourced communities
- Michael A. Preston, Katherine Glover-Collins, Levi Ross, Austin Porter, Zoran Bursac, Delores Woods, Jacqueline Burton, Karen Crowell, Jonathan Laryea, Ronda S. Henry-Tillman
- Postoperative serum Vascular Endothelial Growth Factor is an independent prognostic factor of disease free survival and overall survival in patients with non metastatic colon cancer
- M. Pascual, S. Alonso, S. Salvans, X. Mayol, S. Mojal, M.J. Gil, L. Grande, M. Pera
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?